![Pieter B. M. W. M. Timmermans](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pieter B. M. W. M. Timmermans
Technik-/Wissenschafts-/F&E-Leiter bei Kosan Biosciences, Inc.
Profil
Pieter B.
M.
W.
M.
Timmermans is a professional with a background in drug discovery and preclinical research.
He is currently employed as the SVP-Drug Discovery & Preclinical Research at Kosan Biosciences, Inc. Prior to this, he held the position of VP-Pharmacology & Preclinical Development at Amgen, Inc. and Tularik, Inc. respectively.
He also worked as an Associate Professor at the University of Amsterdam.
Timmermans received his undergraduate and doctorate degrees from the University of Leiden.
Aktive Positionen von Pieter B. M. W. M. Timmermans
Unternehmen | Position | Beginn |
---|---|---|
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 |
Ehemalige bekannte Positionen von Pieter B. M. W. M. Timmermans
Unternehmen | Position | Ende |
---|---|---|
AMGEN INC. | Corporate Officer/Principal | 01.01.2005 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01.01.2004 |
University of Amsterdam | Corporate Officer/Principal | - |
Ausbildung von Pieter B. M. W. M. Timmermans
University of Leiden | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AMGEN INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |